Skip to main content
Clinical Trials/CTRI/2016/03/006712
CTRI/2016/03/006712
Completed
Phase 4

Evaluation of analgesic efficacy of dexmedetomidine as adjuvant with ropivacaine in adductor canal block(ACB).

Govt Medical College And Hospital0 sites105 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients undergoing knee ligament reconstruction surgeries
Sponsor
Govt Medical College And Hospital
Enrollment
105
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 10, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Govt Medical College And Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. ASA physical status I and II of either sex
  • 2\. Age between 18 to 60 years
  • 3\. BMI \>\= 20 to \<\= 30 kg m\-2
  • 4\. Scheduled for ACL reconstruction surgery.

Exclusion Criteria

  • 1\. Patients having history of substance abuse.
  • 2\. Patients with coagulopathy and bleeding disorders.
  • 3\. Preexisting peripheral neuropathy.
  • 4\. Preexisting local infection at the site of block.
  • 5\. Pregnant and lactating women.
  • 6\. Inability to understand functioning of PCA pump and VAS (Visual Analogue Scale).
  • 7\. Contraindication to study drugs ropivacaine, dexmedetomidine and morphine.
  • 8\. Patients having haemodynamic instability, hypotension, bradycardia, hepatic dysfunction.
  • 9\. Patients on regular chronic pain management drugs for the last three months.

Outcomes

Primary Outcomes

Not specified

Similar Trials